IL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production

Area of Science:

• Neuroimmunology
• Inflammatory Diseases
• T cell Biology

Background:

• Multiple sclerosis and EAE are CNS inflammatory diseases driven by Th17 cells.
• Th17 cells secreting GM-CSF are pathogenic in CNS inflammation.
• IL-9's role in suppressing Th17-mediated inflammation in EAE is not fully understood.

Purpose of the Study:

• To investigate the mechanism by which IL-9 modulates EAE development.
• To clarify the role of IL-9 signaling in autoimmune neuroinflammation.

Main Methods:

• Utilized IL-9 receptor knockout (IL-9R-/-) mice to study EAE.
• Analyzed immune cell populations (GM-CSF+ CD4+ T cells, DCs) in the CNS.
• Performed adoptive transfer experiments with dendritic cells (DCs) from wild-type and IL-9R-/- mice.

Main Results:

• IL-9R-/- mice exhibited more severe EAE compared to wild-type counterparts.
• Increased numbers of GM-CSF+ CD4+ T cells and inflammatory DCs were observed in the CNS of IL-9R-/- mice.
• DCs from IL-9R-/- mice enhanced T cell GM-CSF production and exacerbated EAE upon transfer.

Conclusions:

• IL-9 signaling is crucial for controlling autoimmune neuroinflammation in EAE.
• IL-9 suppresses EAE pathogenesis by reducing GM-CSF production in CD4+ T cells.
• IL-9 exerts its effect through the modulation of dendritic cells, impacting T cell responses.